We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPLN:NYSEOPENLANE, Inc. Analysis

Data as of 2026-08-25 - not real-time

$34.15

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

OPENLANE, Inc. trades at $34.15, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 15.3% over the past 30 days. Momentum indicators put RSI at 36.0 (approaching oversold) with MACD reading bearish. The recent range runs from support at $33.11 up to resistance at $42.69.
The shares look undervalued at 19.7 times earnings, though no sector average was available for comparison. Consensus targets land 35.4% above where the shares trade now. Revenue is growing at 15.1% on a 9.7% profit margin.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 34.4%, a beta of 0.86 and a maximum drawdown of 22.1%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

OPENLANE, Inc. NYSE: OPLN "OPENLANE" today announced the pricing of the previously-announced registered public offering...OPENLANE OPLN delivered earnings and revenue surprises of +14.Updated Aug 4, 2026 0 - Marketplace commercial vehicles sold growth of 39% YoY - Marketplace dealer vehicles sold...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 32.28
  • MACD momentum is negative
  • 30-day price change of -15.3%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 32.28
  • Analyst targets imply +35.4% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +35.4% versus the current price
  • Revenue growth of +15.1%
  • P/E ratio of 19.7

Key Metrics & Analysis

Financial Health

Revenue Growth15.10%
Profit Margin9.67%
P/E Ratio19.7
ROE11.15%
ROA4.58%
Debt/Equity157.36
P/B Ratio2.7
Op. Cash Flow$410.1M
Free Cash Flow$26.4M

Technical Analysis

TrendNeutral
RSI36.0
Support$33.11
Resistance$42.69
MA 20$36.67
MA 50$38.58
MA 200$32.28
MACDBearish
VolumeIncreasing
Fear & Greed Index93.32

Valuation

Target Price$46.22
Upside/Downside35.35%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.86
Volatility34.45%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.